 Sensus Healthcare stock fell to lows of 1.9 during 2020, from highs of 9 in mid-2019, owing to a pandemic-induced collapse in annual sales from 27.3m to 9.6m in FY20. The company has developed Superficial Radiation Technology SRT to treat oncological and non-oncological skin conditions, including keloid scarring. 